non-invasive diagnostic tool that can certainly improve clinical outcomes and help personalise treatment for patients.” EDX has filed a patent application for the test and the AI algorithm with ...

CAMBRIDGE, UK - EDX Medical (TASE:PMCN) Group plc (AQSE: EDX), a developer of digital diagnostic tools for personalized healthcare in cancer, cardiovascular, and infectious diseases, announced the ...